# Barnwell Industries Inc: overview BRN · NYSE · CIK 10048 · [Energy](/sectors/energy.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/brn.md) · [Financials](/companies/brn/financials.md) · [Filings](/companies/brn/filings.md) · [Insiders](/companies/brn/insiders.md) Latest reported revenue: [$3.4m](/filings/0001628280-26-055512.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-055512). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [3,729 d](/filings/0001628280-25-058738.md) | [3,934](/filings/0001628280-26-010708.md) | [3,569](/filings/0001628280-26-037042.md) | [3,192](/filings/0001628280-26-055512.md) | [3,002 d](/filings/0001628280-25-058738.md) | [2,746](/filings/0001628280-26-010708.md) | [2,535](/filings/0001628280-26-037042.md) | [3,379](/filings/0001628280-26-055512.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(7.1%) d](/filings/0001628280-25-058738.md) | [(2.7%)](/filings/0001628280-26-010708.md) | [21.7%](/filings/0001628280-26-037042.md) | [1.6%](/filings/0001628280-26-055512.md) | [(23.0%) d](/filings/0001628280-25-058738.md) | [2.5%](/filings/0001628280-26-010708.md) | [3.7%](/filings/0001628280-26-037042.md) | [23.2%](/filings/0001628280-26-055512.md) | | Net margin | % | [(50.5%) d](/filings/0001628280-25-058738.md) | [(48.7%)](/filings/0001628280-26-010708.md) | [(33.8%)](/filings/0001628280-26-037042.md) | [(48.6%)](/filings/0001628280-26-055512.md) | [(80.9%) d](/filings/0001628280-25-058738.md) | [(51.9%)](/filings/0001628280-26-010708.md) | [(45.4%)](/filings/0001628280-26-037042.md) | [(13.0%)](/filings/0001628280-26-055512.md) | | Diluted EPS | $ per share | not reported | [(0.19)](/filings/0001628280-26-010708.md) | [(0.12)](/filings/0001628280-26-037042.md) | [(0.15)](/filings/0001628280-26-055512.md) | not reported | [(0.13)](/filings/0001628280-26-010708.md) | [(0.09)](/filings/0001628280-26-037042.md) | [(0.03)](/filings/0001628280-26-055512.md) | | Free cash flow | $k | not reported | [(3,288)](/filings/0000010048-25-000009.md) | not reported | not reported | not reported | [(1,795)](/filings/0001628280-26-010708.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [18.1](/filings/0000010048-22-000029.md) | [28.5](/filings/0000010048-23-000022.md) | [25.3](/filings/0000010048-24-000020.md) | [18.1](/filings/0001628280-25-058738.md) | [13.7](/filings/0001628280-25-058738.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [35.0%](/filings/0000010048-22-000029.md) | [40.7%](/filings/0000010048-23-000022.md) | [20.5%](/filings/0000010048-24-000020.md) | [1.7%](/filings/0001628280-25-058738.md) | [0.2%](/filings/0001628280-25-058738.md) | | Net margin | % | [34.5%](/filings/0000010048-22-000029.md) | [19.3%](/filings/0000010048-23-000022.md) | [(3.8%)](/filings/0000010048-24-000020.md) | [(30.8%)](/filings/0001628280-25-058738.md) | [(51.9%)](/filings/0001628280-25-058738.md) | | Diluted EPS | $ per share | [0.73](/filings/0000010048-22-000029.md) | [0.57](/filings/0000010048-23-000022.md) | [(0.10)](/filings/0000010048-24-000020.md) | [(0.56)](/filings/0001628280-25-058738.md) | [(0.71)](/filings/0001628280-25-058738.md) | | Free cash flow | $m | [(2.3)](/filings/0000010048-22-000029.md) | [(6.5)](/filings/0000010048-23-000022.md) | [(10.6)](/filings/0000010048-24-000020.md) | [0.5](/filings/0000010048-24-000020.md) | [(2.0)](/filings/0001628280-25-058738.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/brn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [JCP Investment Management, LLC](/funds/1461945.md) | 2026-06-30 | $731.8k | 724,547 | | Added +315,323 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $366.6k | 362,976 | | Reduced −25,144 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $277.1k | 274,323 | | Reduced −49,390 | | [Accretive Wealth Partners, LLC](/funds/1844444.md) | 2026-06-30 | $125.0k | 123,803 | | Reduced −4,400 | | [CWA Asset Management Group, LLC](/funds/1667134.md) | 2026-06-30 | $101.0k | 100,000 | | New +100,000 | | [Aspen Grove Capital, LLC](/funds/1806027.md) | 2026-06-30 | $90.9k | 90,000 | | Added +10,194 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $85.8k | 84,944 | | Unchanged | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $84.6k | 83,787 | | New +83,787 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $68.8k | 68,120 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $53.0k | 52,498 | | Reduced −30,759 | ## Recent filings [All 688 filings](/companies/brn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-19 | 10:30 ET | [8-K](/filings/0001140361-26-039979.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-039979 | | 2026-10-06 | 10:30 ET | [8-K](/filings/0001140361-26-038710.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038710 | | 2026-10-05 | 21:00 ET | [8-K](/filings/0001140361-26-038648.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-038648 | | 2026-09-16 | 11:30 ET | [8-K](/filings/0001140361-26-036721.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036721 | | 2026-08-12 | 22:25 ET | [8-K](/filings/0001140361-26-032289.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032289 | | 2026-08-11 | 12:24 ET | [10-Q](/filings/0001628280-26-055512.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055512 | | 2026-08-04 | 11:15 ET | [8-K](/filings/0001140361-26-031054.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-031054 | | 2026-07-06 | 20:30 ET | [8-K](/filings/0001140361-26-027633.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-027633 | | 2026-05-26 | 20:45 ET | [8-K](/filings/0001140361-26-022863.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-022863 | | 2026-05-21 | 01:59 ET | [10-Q](/filings/0001628280-26-037042.md) | Quarterly report, period 2026-03-31 | 0001628280-26-037042 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001628280-25-058738.md), filed Dec 23, 2025. ## Forecast league Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c38bcabe-ba2b-4cc3-90a3-3d4282e0f966) ## About the filer - CIK: 10048 - Tickers: BRN - Exchange: NYSE - SIC code: 1311 Crude Petroleum & Natural Gas - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.